Cwm LLC Cuts Stock Holdings in Molina Healthcare, Inc $MOH

Cwm LLC trimmed its holdings in shares of Molina Healthcare, Inc (NYSE:MOH) by 7.6% in the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 16,359 shares of the company’s stock after selling 1,345 shares during the period. Cwm LLC’s holdings in Molina Healthcare were worth $4,873,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of MOH. Price T Rowe Associates Inc. MD grew its stake in shares of Molina Healthcare by 46.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 3,838,043 shares of the company’s stock worth $1,264,214,000 after purchasing an additional 1,216,903 shares during the last quarter. AQR Capital Management LLC grew its stake in shares of Molina Healthcare by 42.7% in the first quarter. AQR Capital Management LLC now owns 884,958 shares of the company’s stock worth $288,125,000 after purchasing an additional 264,664 shares during the last quarter. Nuveen LLC bought a new stake in shares of Molina Healthcare in the first quarter worth about $46,441,000. T. Rowe Price Investment Management Inc. grew its stake in shares of Molina Healthcare by 8.6% in the first quarter. T. Rowe Price Investment Management Inc. now owns 1,487,896 shares of the company’s stock worth $490,099,000 after purchasing an additional 117,796 shares during the last quarter. Finally, Durable Capital Partners LP grew its stake in shares of Molina Healthcare by 13.1% in the first quarter. Durable Capital Partners LP now owns 541,605 shares of the company’s stock worth $178,399,000 after purchasing an additional 62,899 shares during the last quarter. 98.50% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

MOH has been the topic of several recent analyst reports. JPMorgan Chase & Co. cut their target price on Molina Healthcare from $272.00 to $184.00 and set a “neutral” rating on the stock in a research note on Tuesday, July 29th. Sanford C. Bernstein lowered their price objective on shares of Molina Healthcare from $284.00 to $220.00 and set an “outperform” rating for the company in a report on Friday, September 5th. Cantor Fitzgerald restated a “neutral” rating and issued a $210.00 price objective on shares of Molina Healthcare in a report on Tuesday, August 26th. Barclays lowered their price objective on shares of Molina Healthcare from $186.00 to $185.00 and set an “equal weight” rating for the company in a report on Thursday, September 4th. Finally, Weiss Ratings restated a “sell (d+)” rating on shares of Molina Healthcare in a report on Wednesday, October 8th. Three research analysts have rated the stock with a Buy rating, twelve have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Molina Healthcare has a consensus rating of “Hold” and a consensus price target of $222.15.

Insider Buying and Selling

In other Molina Healthcare news, Director Ronna Romney sold 700 shares of Molina Healthcare stock in a transaction that occurred on Wednesday, August 6th. The shares were sold at an average price of $153.74, for a total value of $107,618.00. Following the completion of the sale, the director owned 17,131 shares of the company’s stock, valued at approximately $2,633,719.94. The trade was a 3.93% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, COO James Woys bought 10,000 shares of the business’s stock in a transaction on Monday, August 4th. The stock was bought at an average cost of $155.94 per share, with a total value of $1,559,400.00. Following the transaction, the chief operating officer owned 74,331 shares in the company, valued at $11,591,176.14. This trade represents a 15.54% increase in their position. The disclosure for this purchase can be found here. Insiders own 1.10% of the company’s stock.

Molina Healthcare Price Performance

Shares of NYSE MOH opened at $188.26 on Friday. Molina Healthcare, Inc has a twelve month low of $151.95 and a twelve month high of $359.97. The firm has a market cap of $10.20 billion, a P/E ratio of 9.28 and a beta of 0.55. The company has a 50 day moving average of $181.22 and a 200 day moving average of $245.68. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.77.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings data on Wednesday, July 23rd. The company reported $5.48 earnings per share for the quarter, missing analysts’ consensus estimates of $5.50 by ($0.02). Molina Healthcare had a return on equity of 27.72% and a net margin of 2.60%.The firm had revenue of $11.43 billion during the quarter, compared to analysts’ expectations of $10.94 billion. During the same quarter in the previous year, the firm earned $5.86 earnings per share. Molina Healthcare’s revenue was up 15.7% on a year-over-year basis. As a group, research analysts expect that Molina Healthcare, Inc will post 24.4 EPS for the current fiscal year.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.